Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2022-09-07 AGM Information
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房2022年第四次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as meeting materials for the "2022 Fourth Extraordinary General Meeting" of Yifeng Pharmacy Chain Co., Ltd. It contains detailed agenda items, meeting instructions, and multiple proposals related to the issuance of convertible bonds, including bond issuance conditions, bond issuance plans, feasibility reports, and reports on the use of previously raised funds. The document is clearly a set of materials prepared for a shareholders' meeting, including proposals to be voted on and discussed. It is not a transcript of a call, an earnings release, or a standalone audit report. It is not a full annual or interim report but rather meeting materials for a specific shareholders meeting. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting or Extraordinary General Meeting. The document length is substantial (15,000 characters), and it contains detailed meeting agenda and proposals, not just an announcement or a brief notice. Therefore, the correct classification is AGM Information (AGM-R).
2022-09-07 Chinese
湖南启元律师事务所关于益丰大药房连锁股份有限公司2022年第三次临时股东大会的法律意见书
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and validity of the procedures, attendance, and voting results of the 2022 third extraordinary shareholders' meeting of the company. It details the verification of meeting notices, attendance, voting methods, and results, and concludes on the compliance with relevant laws and company articles. This is a legal proceedings related document providing an opinion on a specific shareholders' meeting, not a financial report, announcement of voting results, or management information. It does not fit into categories like AGM Information, Declaration of Voting Results, or Board/Management Information. The best fitting category is Legal Proceedings Report (LTR) as it involves legal opinion on corporate governance matters related to a shareholders' meeting.
2022-09-05 Chinese
益丰药房关于2022年限制性股票激励计划内幕信息知情人的自查报告
Regulatory Filings Classification · 95% confidence The document is a self-inspection report related to insider information holders for a 2022 restricted stock incentive plan by the company. It discusses compliance with disclosure regulations, internal controls, and confirms no insider trading occurred before the announcement. The document is an announcement about insider trading checks and compliance related to a stock incentive plan, not a financial report, earnings release, or management discussion. It is regulatory in nature, related to compliance and disclosure obligations under securities laws. The document length is short (984 characters) and it is a formal announcement rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS).
2022-09-05 Chinese
益丰药房2022年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the company's third extraordinary general meeting in 2022. It details the meeting date, attendance, voting results on specific proposals, and legal witness statements confirming the validity of the meeting and voting process. The content focuses on the announcement of voting results from a shareholder meeting rather than the meeting materials or the meeting itself. There is no financial report or presentation included, only the official voting outcomes and related procedural confirmations. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2382 characters, which is consistent with a detailed voting results announcement rather than a full report or presentation.
2022-09-05 Chinese
关于益丰大药房连锁股份有限公司前次募集资金使用情况鉴证报告（截至2022年6月30日）
Regulatory Filings
2022-08-29 Chinese
益丰药房第四届董事会第十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 17th meeting of the 4th Board of Directors of Yifeng Pharmacy Chain Co., Ltd. It includes multiple agenda items such as approval of the 2022 semi-annual report, special reports on fundraising usage, proposals related to convertible bonds issuance, bank credit increases, and other corporate governance matters. The document references various reports and announcements that are published separately on the Shanghai Stock Exchange website, indicating that this document itself is a board meeting resolution announcement rather than the reports themselves. The document is not a full financial report but a formal disclosure of board decisions and approvals, including proposals to be submitted to the shareholders' meeting. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. The document length (7111 characters) and content confirm it is not a brief announcement nor a full financial report but a comprehensive board meeting resolution announcement.
2022-08-29 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.